We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
Cap. Flow
-$1.56B
Cap. Flow %
-3.42%
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$352M
2
KR icon
Kroger
KR
+$279M
3
T icon
AT&T
T
+$235M
4
INTC icon
Intel
INTC
+$217M
5
EW icon
Edwards Lifesciences
EW
+$212M

Sector Composition

Rank Sector Weight
1 Financials 19.08%
2 Technology 16.14%
3 Healthcare 15.45%
4 Consumer Discretionary 9.74%
5 Consumer Staples 5.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUTR
2626
DELISTED
Cutera, Inc.
CUTR
$587K ﹤0.01%
+12,900
New +$588K
GMDA
2627
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$586K ﹤0.01%
368,899
+143,968
+64% +$328K
CNTY icon
2628
Century Casinos
CNTY
$32.9M
$583K ﹤0.01%
88,781
+45,186
+104% +$348K
ITA icon
2629
iShares US Aerospace & Defense ETF
ITA
$14B
$583K ﹤0.01%
+6,400
New +$647K
CINF icon
2630
Cincinnati Financial
CINF
$27.8B
$582K ﹤0.01%
6,501
-34,939
-84% -$3.6M
NUS icon
2631
Nu Skin
NUS
$257M
$582K ﹤0.01%
17,467
+3,701
+27% +$154K
RWR icon
2632
State Street SPDR Dow Jones REIT ETF
RWR
$1.9B
$581K ﹤0.01%
6,891
-26,800
-80% -$2.61M
BIOX icon
2633
Bioceres Crop Solutions
BIOX
$20.6M
$579K ﹤0.01%
44,419
+13,271
+43% +$163K
TUR icon
2634
CALL
iShares MSCI Turkey ETF
TUR
$201M
$573K ﹤0.01%
26,000
-67,700
-72% -$1.43M
KORE.WS
2635
CALL
DELISTED
KORE Group Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
KORE.WS
$573K ﹤0.01%
300,000
CMTG icon
2636
Claros Mortgage Trust
CMTG
$290M
$567K ﹤0.01%
48,286
+31,774
+192% +$545K
STRS icon
2637
Stratus Properties
STRS
$155M
$567K ﹤0.01%
+24,329
New +$768K
SKYT icon
2638
SkyWater Technology
SKYT
$1.5B
$566K ﹤0.01%
+73,937
New +$872K
EVBG
2639
DELISTED
Everbridge, Inc. Common Stock
EVBG
$566K ﹤0.01%
18,333
-21,619
-54% -$709K
REVEW
2640
CALL
DELISTED
Alpine Acquisition Corp Warrant
REVEW
$565K ﹤0.01%
55,079
MMSI icon
2641
Merit Medical Systems
MMSI
$4.82B
$564K ﹤0.01%
9,969
-6,875
-41% -$396K
DCO icon
2642
Ducommun
DCO
$2.56B
$562K ﹤0.01%
14,145
+4,854
+52% +$216K
HOV icon
2643
Hovnanian Enterprises
HOV
$779M
$562K ﹤0.01%
+15,700
New +$695K
BKSY.WS icon
2644
CALL
BlackSky Technology Inc Warrants
BKSY.WS
$552K
$560K ﹤0.01%
373,168
-27,421
-7% -$8.03K
ATRC icon
2645
AtriCure
ATRC
$2.08B
$559K ﹤0.01%
14,282
-7,262
-34% -$332K
HLGN.WS
2646
CALL
DELISTED
Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50
HLGN.WS
$558K ﹤0.01%
300,000
XLV icon
2647
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$42.9B
$557K ﹤0.01%
+4,600
New +$593K
FPXI icon
2648
First Trust Exchange-Traded Fund II First Trust International Equity Opportunities ETF
FPXI
$261M
$556K ﹤0.01%
15,563
-2,400
-13% -$99.1K
OHPAW
2649
CALL
DELISTED
Orion Acquisition Corp. Warrant
OHPAW
$554K ﹤0.01%
56,278
AMPS.WS
2650
CALL
DELISTED
Altus Power Warrants
AMPS.WS
$552K ﹤0.01%
50,200
+200
+0.4% +$504

Similar funds

Marshall Wace's Q3 2022 Portfolio in Review

As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.

  • Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
  • Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
  • Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
  • Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
  • Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
  • Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
  • Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.

Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.